Related Experiment Video
Updated: Jul 14, 2026

Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
Risk of target lesion revascularization after coronary stenting in patients with and without chronic kidney disease
David Charytan1, John P Forman, Donald E Cutlip
1Department of Medicine, Brigham and Women's Hospital, Renal Division, Clinical Biometrics, 1 Brigham Circle, 3rd Floor, Boston, MA 02115, USA. dcharytan@partners.org
Insights
Mild to moderate chronic kidney disease (CKD) did not increase the overall risk of target lesion revascularization after coronary stenting. However, long-term outcomes may be less favorable for patients with CKD, warranting further investigation.
Area of Science:
- Cardiology
- Nephrology
- Interventional Cardiology
Background:
- High restenosis rates are noted in advanced renal failure patients post-percutaneous coronary intervention (PCI) with stenting.
- The impact of mild to moderate chronic kidney disease (CKD) on target lesion revascularization (TLR) after coronary stenting remains uncertain.
Purpose of the Study:
- To investigate the association between mild to moderate CKD and short-term and long-term TLR risk following coronary stenting.
- To compare the effectiveness of coronary stenting in patients with and without mild to moderate CKD.
Main Methods:
- Analysis of 1228 patients from four randomized trials undergoing elective coronary angioplasty with stenting.
- Prospective 5-year follow-up and Cox proportional hazards regression to assess TLR risk in patients with vs. without mild to moderate CKD.
Main Results:
- No significant increase in overall TLR risk was observed for mild (HR 1.07) or moderate (HR 0.95) CKD.
- A non-significant trend towards increased late TLR risk (HR 1.40) was noted in patients with mild to moderate CKD.
- TLR was required in 16.7% of patients overall, with 4.8% occurring after the first year.
Conclusions:
- Coronary stenting demonstrates similar short-term effectiveness in patients with mild to moderate CKD and those with normal renal function.
- While late TLR is uncommon, long-term results of coronary stenting may be less favorable in patients with CKD.
- Further research into long-term outcomes for CKD patients undergoing stenting is warranted.
Background:
Rates of restenosis following percutaneous coronary intervention with stent placement are high in patients with advanced renal failure. Whether mild to moderate chronic kidney disease (CKD) is associated with a similarly increased need for short or long-term target lesion revascularization (TLR) following coronary stenting is uncertain.
Methods:
We analysed results from 1228 patients enrolled in four separate, randomized, controlled clinical trials who underwent elective coronary angioplasty with stenting and were prospectively followed for 5 years after the index procedure. Cox proportional hazards regression was used to correct for confounding and to estimate the short and long-terms risks of target lesion revascularization in patients with vs without mild to moderate CKD.
Results:
During a median follow-up of 5 years, 205 patients (16.7%) required TLR with 59 (4.8%) requiring TLR after the first year. Mild (HR 1.07, 95% CI 0.74-1.53) and moderate (HR 0.95, 95% CI 0.552-1.64) CKD were not associated with an increase in the adjusted, overall-risk of TLR. However, mild to moderate CKD was associated with a non-significantly increased risk of late TLR (HR 1.40, 95% CI 0.73-2.69).
Conclusions:
Coronary stenting appears to be similarly effective in patients with mild to moderate CKD and patients with normal renal function. While target lesion revascularization is rarely needed beyond the first year after revascularization, long-term results of coronary stenting may be less-favourable in patients with CKD.
Related Concept Videos
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Chronic Kidney Disease III: Interprofessional Care
Chronic Kidney Disease I: Introduction
Cardiac Catheterization I: Pre-Procedure Overview
Chronic Kidney Disease II: Clinical Manifestations
Kidney Transplant I: Introduction